81. EbolaŚClinical Virology: Virus to the Bedside
Thursday, October 8, 2015: 2:00 PM-3:30 PM
Room: 6--AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe Ebola disease characteristics and immune response
  • select therapeutic interventions
  • discuss the status of vaccine development, and use of personal protective equipment and infection control to prevent disease

Target Audience: Scientists, Vaccinologists, Nurses, Microbiologists, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Global ID, Epidemiology and Infection Control, Adult ID, Trainee

Moderator:  Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases

2:00 PM
Ebola 101
Anita Mcelroy, MD, PhD

2:30 PM
Ebola Treatment
William Fischer II, MD
3:00 PM
Ebola Vaccine ľ Liberia Vaccine Trial
Stephen B. Kennedy, MD, MPH, PI

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-157-L01-P


I. Damon, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.